Results 71 to 80 of about 36,401 (249)

Glucocorticoid‐induced hyperglycaemia in hospitalised adults: A matched cohort study (2013–2023)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the risk of new‐onset hyperglycaemia between inpatients treated versus non‐treated with systemic glucocorticoids and identify factors associated with glucocorticoid‐induced hyperglycaemia (GIH). Materials and methods We conducted a cohort study using electronic healthcare records of adults admitted to the Oxford University ...
Rajna Golubic, Hudson Mumbole, Ruth L. Coleman, Rustam Rea, Rohini Mathur, Rishi Caleyachetty, Amanda I. Adler   +6 more
wiley   +1 more source

Diabetic coma without ketoacidosis. [PDF]

, 1965

openalex   +1 more source

A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors

Diabetes, Obesity and Metabolism, EarlyView.
Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley   +1 more source

Insulin Therapy in Diabetic Hyperglycemic Emergencies

Revista Finlay, 2014
Background: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state are two of the most serious metabolic emergencies in diabetic patients.
Diana Machado Ramírez, Manuel Licea Puig   +1 more
doaj   +2 more sources

Diabetic Coma Without Ketoacidosis in a Patient With Acute Pancreatitis [PDF]

, 1964
Alexander Davidson
openalex   +1 more source

Real world evidence of insulin and biosimilar insulin therapy—Opportunities to improve adherence, outcomes and cost‐effectiveness

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use
Aimin Yang, Jiazhou Yu, Johnny T. K. Cheung, Juliana C. N. Chan, Elaine Chow   +4 more
wiley   +1 more source

Significance of Hyperamylasaemia and Abdominal Pain in Diabetic Ketoacidosis [PDF]

, 1973
A H Knight, David N. Williams, Gregory Ellis, David M. Goldberg   +3 more
openalex   +1 more source

Diabetic ketoacidosis [PDF]

Pediatric Diabetes, 2007
Joseph, Wolfsdorf, Maria E, Craig, Denis, Daneman, David, Dunger, Julie, Edge, W R Warren, Lee, Arlan, Rosenbloom, Mark A, Sperling, Ragnar, Hanas   +8 more
openaire   +4 more sources

Letter: Cerebral oedema in diabetic ketoacidosis. [PDF]

, 1975
Jeffrey K. Moore
openalex   +3 more sources

SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report

Kidney Medicine, 2020
Euglycemic diabetic ketoacidosis is a rare but serious adverse effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors. We present a case of a woman in her 40s with type 2 diabetes mellitus hospitalized for revascularization for moyamoya disease who ...
Katherine M. Wang, Robert T. Isom
doaj